Turkish nationwide survEy of glycemic and other Metabolic parameters of patients with Diabetes mellitus (TEMD study)

dc.contributor.authorSonmez A.
dc.contributor.authorHaymana C.
dc.contributor.authorBayram F.
dc.contributor.authorSalman S.
dc.contributor.authorDizdar O.S.
dc.contributor.authorGurkan E.
dc.contributor.authorKargili Carlıoglu A.
dc.contributor.authorBarcin C.
dc.contributor.authorSabuncu T.
dc.contributor.authorSatman I.
dc.contributor.authorGuldiken S.
dc.contributor.authorAyturk S.
dc.contributor.authorYilmaz M.
dc.contributor.authorAsik M.
dc.contributor.authorDinccag N.
dc.contributor.authorCakmak R.
dc.contributor.authorTurker F.
dc.contributor.authorIdiz C.
dc.contributor.authorHacisahinogullari H.
dc.contributor.authorBagdemir E.
dc.contributor.authorYildiz B.
dc.contributor.authorYumuk V.D.
dc.contributor.authorHaliloglu O.
dc.contributor.authorSancak S.
dc.contributor.authorOzsari L.
dc.contributor.authorCagiltay E.
dc.contributor.authorDeyneli O.
dc.contributor.authorImre E.
dc.contributor.authorGonen S.
dc.contributor.authorBoysan S.N.
dc.contributor.authorAltuntas Y.
dc.contributor.authorOzturk F.Y.
dc.contributor.authorMert M.
dc.contributor.authorPiskinpasa H.
dc.contributor.authorAydin H.
dc.contributor.authorImamoglu S.
dc.contributor.authorErsoy C.
dc.contributor.authorGul O.O.
dc.contributor.authorKucuksarac Kiyici S.
dc.contributor.authorCetinarslan B.
dc.contributor.authorSelek A.
dc.contributor.authorDogru T.
dc.contributor.authorKirik A.
dc.contributor.authorKebapci N.
dc.contributor.authorEfe B.
dc.contributor.authorKaya A.
dc.contributor.authorCordan I.
dc.contributor.authorBaldane S.
dc.contributor.authorKirac C.O.
dc.contributor.authorDemirci I.
dc.contributor.authorCapa Z.
dc.contributor.authorCesur M.
dc.contributor.authorYetkin I.
dc.contributor.authorCorapcioglu D.
dc.contributor.authorCanlar S.
dc.contributor.authorBulent Yildiz O.
dc.contributor.authorSendur S.N.
dc.contributor.authorCakir B.
dc.contributor.authorOzdemir D.
dc.contributor.authorCorakci A.
dc.contributor.authorKutlu M.
dc.contributor.authorBascil Tutuncu N.
dc.contributor.authorBozkus Y.
dc.contributor.authorCakal E.
dc.contributor.authorDemirbas B.
dc.contributor.authorErtek S.
dc.contributor.authorAltay M.
dc.contributor.authorDagdeviren M.
dc.contributor.authorAbedi A.H.
dc.contributor.authorCetinkalp S.
dc.contributor.authorOzisik H.
dc.contributor.authorOruk G.G.
dc.contributor.authorYener S.
dc.contributor.authorSaydam B.O.
dc.contributor.authorGuney E.
dc.contributor.authorUnubol M.
dc.contributor.authorYaylali G.F.
dc.contributor.authorTopsakal S.
dc.contributor.authorHekimsoy Z.
dc.contributor.authorAkbaba G.
dc.contributor.authorAslan I.
dc.contributor.authorBalci M.K.
dc.contributor.authorDalkiran S.
dc.contributor.authorAkbay E.
dc.contributor.authorGul K.
dc.contributor.authorAgbaht K.
dc.contributor.authorYilmaz M.O.
dc.contributor.authorBozkirli E.
dc.contributor.authorTetiker B.T.
dc.contributor.authorCetinkaya Altuntas S.
dc.contributor.authorAtmaca A.
dc.contributor.authorDurmuş E.T.
dc.contributor.authorMete T.
dc.contributor.authorKutluturk F.
dc.contributor.authorKucukler F.K.
dc.contributor.authorDikbas O.
dc.contributor.authorAkin S.
dc.contributor.authorNuhoglu I.
dc.contributor.authorErsoz H.O.
dc.contributor.authorBayraktaroglu T.
dc.contributor.authorSisman P.
dc.contributor.authorSahin I.
dc.contributor.authorCetin S.
dc.contributor.authorCapoglu I.
dc.contributor.authorAkbas E.M.
dc.contributor.authorUcler R.
dc.contributor.authorEren M.A.
dc.contributor.authorTuzcu A.K.
dc.contributor.authorPekkolay Z.
dc.contributor.authorOzkaya M.
dc.contributor.authorAraz M.
dc.date.accessioned2024-07-22T08:09:24Z
dc.date.available2024-07-22T08:09:24Z
dc.date.issued2018
dc.description.abstractAims: Turkey has the highest prevalence of diabetes in Europe. It is therefore essential to know the overall cardiovascular risk and reveal the predictors of metabolic control in Turkish adults with diabetes mellitus. Methods: A nationwide, multicenter survey consecutively enrolled patients who were under follow up for at least a year. Optimal control was defined as HbA1c < 7%, home arterial blood pressure (ABP) < 135/85 mmHg, or LDL-C < 100 mg/dL. Achieving all parameters indicated triple metabolic control. Results: HbA1c levels of patients (n = 5211) were 8.6 ± 1.9% (71 ± 22 mmol/mol) and 7.7 ± 1.7% (61 ± 19 mmol/mol), in Type 1 and Type 2 diabetes, respectively. Glycemic control was achieved in 15.3% and 40.2%, and triple metabolic control was achieved in 5.5% and 10.1%, respectively. Only 1.5% of patients met all the criteria of being non-obese, non-smoker, exercising, and under triple metabolic control. Low education level was a significant predictor of poor glycemic control in both groups. Conclusions: Few patients with Type 2, and even fewer with Type 1 diabetes have optimal metabolic control in Turkey. TEMD study will provide evidence-based information to policy makers to focus more on the quality and sustainability of diabetes care in order to reduce the national burden of the disease. © 2018 Elsevier B.V.
dc.identifier.DOI-ID10.1016/j.diabres.2018.09.010
dc.identifier.issn01688227
dc.identifier.urihttp://akademikarsiv.cbu.edu.tr:4000/handle/123456789/14810
dc.language.isoEnglish
dc.publisherElsevier Ireland Ltd
dc.subjectAdult
dc.subjectBlood Glucose
dc.subjectCross-Sectional Studies
dc.subjectDiabetes Mellitus, Type 2
dc.subjectEurope
dc.subjectFemale
dc.subjectGlycated Hemoglobin A
dc.subjectHumans
dc.subjectMale
dc.subjectSurveys and Questionnaires
dc.subjectTurkey
dc.subjectglucose
dc.subjecthemoglobin A1c
dc.subjecthigh density lipoprotein cholesterol
dc.subjectinsulin
dc.subjectlow density lipoprotein cholesterol
dc.subjecttriacylglycerol
dc.subjectglycosylated hemoglobin
dc.subjectadult
dc.subjectanthropometry
dc.subjectArticle
dc.subjectblood pressure measurement
dc.subjectbody mass
dc.subjectcontrolled study
dc.subjectcross-sectional study
dc.subjectdiabetes mellitus
dc.subjectdyslipidemia
dc.subjecteducation
dc.subjectenzyme chemistry
dc.subjectexercise
dc.subjectfemale
dc.subjectglycemic control
dc.subjecthealth survey
dc.subjecthigh performance liquid chromatography
dc.subjecthuman
dc.subjecthypertension
dc.subjecthypoglycemia
dc.subjectimmunoturbidimetry
dc.subjectinsulin dependent diabetes mellitus
dc.subjectmajor clinical study
dc.subjectmale
dc.subjectmetabolic parameters
dc.subjectmiddle aged
dc.subjectnon insulin dependent diabetes mellitus
dc.subjectobesity
dc.subjectprevalence
dc.subjectquestionnaire
dc.subjectrisk factor
dc.subjectsmoking
dc.subjectblood
dc.subjectclinical trial
dc.subjectEurope
dc.subjectglucose blood level
dc.subjectmetabolism
dc.subjectmulticenter study
dc.subjectturkey (bird)
dc.titleTurkish nationwide survEy of glycemic and other Metabolic parameters of patients with Diabetes mellitus (TEMD study)
dc.typeArticle

Files